Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin

Autor:	Ghelardi, Filippo, Raimondi, Alessandra, Morano, Federica, Randon, Giovanni, Pannone, Alessandra, Guaglio, Marcello, Mazzoli, Giacomo, Nasca, Vincenzo, Milione, Massimo, Leoncini, Giuseppe, Sabella, Giovanna, Greco, Gabriella Francesca, Lampis, Bianca Rosa, Galassi, Margherita, Delfanti, Sara, Nannini, Margherita, Intini, Rossana, Baratti, Dario, Di Bartolomeo, Maria, Deraco, Marcello, Pietrantonio, Filippo
Zdroj:	In Clinical Colorectal Cancer December 2023 22(4):450-456
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect